Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HCA Healthcare Inc. (HCA:NYSE), powered by AI.
HCA Healthcare Inc. is currently trading at $396.93. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for HCA Healthcare Inc. on Alpha Lenz.
HCA Healthcare Inc.'s P/E ratio is 13.1.
“HCA Healthcare Inc. trades at a P/E of 13.1 (undervalued) with modest ROE of -159.1%.”
Ask for details →HCA Healthcare Inc. is a leading healthcare services company that owns and operates healthcare facilities across the United States. It plays a critical role in the healthcare sector by providing comprehensive medical care through its network of hospitals, surgery centers, and urgent care facilities. HCA Healthcare Inc. is renowned for its substantial investments in patient care technology and practice management. The company spans various segments of the healthcare industry, delivering services ranging from acute care to outpatient and specialty healthcare. Its operational reach extends across numerous states, significantly influencing healthcare accessibility and quality of medical services in urban and rural communities alike. Moreover, HCA Healthcare emphasizes clinical excellence, research, and education, contributing to the advancement of medical practices and healthcare innovation. HCA Healthcare Inc.'s extensive network and strategic initiatives enable it to adapt to the dynamic healthcare landscape, offering critical services like emergency care, labor and delivery, and oncology. As a pivotal entity in the healthcare sector, it underscores the importance of integrated health systems in enhancing patient outcomes and supporting community well-being.
“HCA Healthcare Inc. trades at a P/E of 13.1 (undervalued) with modest ROE of -159.1%.”
Ask for details →HCA Healthcare Inc. (ticker: HCA) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 226,000 employees. Market cap is $89.2B.
The current price is $396.93 with a P/E ratio of 13.14x and P/B of -14.79x.
ROE is -159.14% and operating margin is 15.83%. Annual revenue is $75.6B.